The assessment of early osteoarthritis

Journal of Bone and Joint Surgery - Series B

Volumn 90, Issue 4, 2008, Pages 411-421

  Pollard, T C B ^a,b   Gwilym, S E ^a,b   Carr, A J ^a,b  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GADOLINIUM PENTETATE; RISEDRONIC ACID;

ARTHROGRAPHY; BONE RADIOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE PREDISPOSITION; ECHOGRAPHY; GENETIC MARKER; HIP OSTEOTOMY; HUMAN; INFLAMMATION; KNEE OSTEOTOMY; KNEE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OSTEOTOMY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW;

AGED; ARTHROPLASTY, REPLACEMENT; BIOLOGICAL MARKERS; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE;

EID: 42149149339     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.90B4.20284     Document Type: Review

References (105)

1. Dixon T, Shaw M, Ebrahim S, Dieppe P. Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need. Ann Rheum Dis 2004;63:825-30.
2. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg [Am] 2007;89-A:780-5.
3. Pritzker KPH. Pathology of osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. Second ed. Oxford: Oxford University Press, 2003:49-58.
4. Altman RD, Bloch DA, Dougados M, et al. Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group. Osteoarthritis Cartilage 2004;12:515-24.
5. Felson DT, Kim YJ. The futility of current approaches to chondroprotection. Arthritis Rheum 2007;56:1378-83.
6. Buckwalter JA, Mankin HJ, Grodzinsky AJ. Articular cartilage and osteoarthritis. Instr Course Lect 2005;54:465-80.
7. Aigner T, McKenna L. Molecular pathology and pathobiology of osteoarthritis cartilage. Cell Mol Life Sci 2002;59:5-18.
8. Heinegard DB, Bayliss M, Lorenzo P. Biochemistry and metabolism of normal and osteoarthritic cartilage. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. Second ed. Oxford: Oxford University Press, 2003:74-84.
9. Alford JW, Cole BJ. Cartilage restoration, part 1: basic science, historical perspective, patient evaluation, and treatment options. Am J Sports Med 2005;33:295-306.
10. Mitchell PG, Magna HA, Reeves LM, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
11. Lee ER, Lamplugh L, Leblond CP, et al. Immunolocalization of the cleavage of the aggrecan core protein at the Asn341-Phe342 bond, as an indicator of the location of the metalloproteinase active in the lysis of the rat growth plate. Anat Rec 1998;252:117-32.
12. Arner EC, Pratta MA, Trzaskos JM, Decicco CP, Tortorella MD. Generation and characterization of aggrecanase: a soluble, cartilage-derived aggrecan-degrading activity. J Biol Chem 1999;274:6594-601.
13. Abbaszade I, Liu RQ, Yang F, et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 1999;274:23443-50.
14. Dijkgraaf LC, de Bont LG, Boering G, Liem RS. The structure, biochemistry, and metabolism of osteoarthritic cartilage: a review of the literature. J Oral Maxillofac Surg 1995;53:1182-92.
15. Sandell LJ. Modern molecular analysis of a traditional disease: progression in osteoarthritis. Arthritis Rheum 2007;56:2474-7.
16. Xu L, Peng H, Glasson S, et al. Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. Arthritis Rheum 2007;56:2663-73.
17. Yasuda T, Tchetina E, Ohsawa K, et al. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage. Matrix Biol 2006;25:419-29.
18. Zack MD, Arner EC, Anglin CP, et al. Identification of fibronectin neoepitopes present in human osteoarthritic cartilage. Arthritis Rheum 2006;54:2912-22.
19. Stanton H, Ung L, Fosang AJ. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases. Biochem J 2002;364:181-90.
20. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritis human hips. II: correlation of morphology with biochemical and metabolic data. J Bone Joint Surg [Am] 1971;53-A:523-37.
21. Pritzker KP, Gay S, Jimenez SA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006;14:13-29.
22. Lorenzo P, Bayliss MT, Heinegård D. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis. Matrix Biol 2004;23:381-91.
23. Kellgren J, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
24. Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage 2007;15(Suppl A):1-56.
25. Hammad TA. Structure modification in knee osteoarthritis: methodology and outcome parameters. Osteoarthritis Cartilage 2001;9:488-98.
26. Buckland-Wright C. Review of the anatomical and radiological differences between fluoroscopic and non-fluoroscopic positioning of osteoarthritic knees. Osteoarthritis Cartilage 2006;14(Suppl A):19-31.
27. Alvarez C, Chicheportiche V, Lequesne M, Vicaut E, Laredo JD. Contribution of helical computed tomography to the evaluation of early hip osteoarthitis: a study in 18 patients. Joint Bone Spine 2005;72:578-84.
28. Nishii T, Tanaka H, Nakanishi K, et al. Fat-suppressed 3D spoiled gradient-echo MRI and MDCT arthrography of articular cartilage in patients with hip dysplasia. AJR Am J Roentgenol 2005;185:379-85.
29. Eckstein F, Burstein D, Link TM. Quantitative MRI of cartilage and bone: degenerative changes in osteoarthritis. NMR Biomed 2006;19:822-54.
30. Shindle MK, Foo LF, Kelly BT, et al. Magnetic resonance imaging of cartilage in the athlete: current techniques and spectrum of disease. J Bone Joint Surg [Am] 2006;88-A(Suppl 4):27-46.
31. Peterfy GG, Guermazi A, Zaim S, et al. Whole-organ magnetic resonance imaging score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage 2004;12:177-90.
32. Bruyere O, Genant H, Kothari M, et al. Longitudinal study of magnetic resonance imaging and standard X-rays to assess disease progression in osteoarthritis. Osteoarthritis Cartilage 2007;15:98-103.
33. Amin S, LaValley MP, Guermazi A, et al. The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. Arthritis Rheum 2005;52:3152-9.
34. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes. Arthritis Res Ther 2006;8:21.
35. Gray ML, Eckstein F, Peterfy C, et al. Toward imaging biomarkers for osteoarthritis. Clin Orthop 2004;427(Suppl):175-81.
36. Burstein D, Gray M. New MRI techniques for imaging cartilage. J Bone Joint Surg [Am] 2003;85-A(Suppl 2):70-7.
37. Burstein D, Gray ML. Is MRI fulfilling its promise for molecular imaging of cartilage in arthritis? Osteoarthritis Cartilage 2006;14:1087-90.
38. Williams A, Sharma L, McKenzie CA, Prasad PV, Burstein D. Delayed gadolinium-enhanced magnetic resonance imaging of cartilage in knee osteoarthritis: findings at different radiographic stages of disease and relationship to malalignment. Arthritis Rheum 2005;52:3528-35.
39. Tiderius C, Hori M, Williams A, et al. dGEMRIC as a function of BMI. Osteoarthritis Cartilage 2006;14:1091-7.
40. Burstein D, Velyvis J, Scott KT, et al. Protocol issues for delayed Gd(DTPA)(2)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn Reson Med 2001;45:36-41.
41. Gillis A, Gray M, Burstein D. Relaxivity and diffusion of gadolinium agents in cartilage. Magn Reson Med 2002;48:1068-71.
42. Tiderius CJ, Jessel R, Kim YJ, Burstein D. Hip dGEMRIC in asymptomatic volunteers and patients with early osteoarthritis: the influence of timing after contrast injection. Magn Reson Med 2007;57:803-5.
43. Roos EM, Dahlberg L. Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: four-month, randomized, controlled trial in patients at risk of osteoarthritis. Arthritis Rheum 2005;52:3507-14.
44. Tiderius CJ, Olsson LE, Nyquist F, Dahlberg L. Cartilage glycosaminoglycan loss in the acute phase after an anterior cruciate ligament injury: delayed gadolinium-enhanced magnetic resonance imaging of cartilage and synovial fluid analysis. Arthritis Rheum 2005;52:120-7.
45. Young AA, Stanwell P, Williams A, et al. Glycosaminoglycan content of knee cartilage following posterior cruciate ligament rupture demonstrated by delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC): a case report. J Bone Joint Surg [Am] 2005;87-A:2763-7.
46. Cunningham T, Jessel R, Zurakowski D, Millis MB, Kim YJ. Delayed gadolinium-enhanced magnetic resonance imaging of cartilage to predict early failure of Bernese periacetabular osteotomy for hip dysplasia. J Bone Joint Surg [Am] 2006;88-A:1540-8.
47. Kim YJ, Jaramillo D, Millis MB, Gray ML, Burstein D. Assessment of early osteoarthritis in hip dysplasia with delayed gadolinium-enhanced magnetic resonance imaging of cartilage. J Bone Joint Surg [Am] 2003;85-A:1987-92.
48. Tiderius CJ, Olsson LE, Leander P, Ekberg O, Dahlberg L. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis. Magn Reson Med 2003;49:488-92.
49. Kurkijärvi JE, Mattila L, Ojala RO, et al. Evaluation of cartilage repair in the distal femur after autologous chondrocyte transplantation using T2 relaxation time and dGEMRIC. Osteoarthritis Cartilage 2007;15:372-8.
50. Gillis A, Bashir A, McKeon B, et al. Magnetic resonance imaging of relative glycosaminoglycan distribution in patients with autologous chondrocyte transplants. Invest Radiol 2001;36:743-8.
51. Hattori K, Takakura Y, Tanaka Y, et al. Quantitative ultrasound can assess living human cartilage. J Bone Joint Surg [Am] 2006;88-A(Suppl 4):201-12.
52. Saarakkala S, Laasanen MS, Jurvelin JS, Töyräs J. Quantitative ultrasound imaging detects degenerative changes in articular cartilage surface and subchondral bone. Phys Med Biol 2006;51:5333-46.
53. Spriet MP, Girard CA, Foster SF, et al. Validation of a 40 MHz B-scan ultrasound biomicroscope for the evaluation of osteoarthritis lesions in an animal model. Osteoarthritis Cartilage 2005;13:171-9.
54. Beck M, Kalhor M, Leunig M, Ganz R. Hip morphology influences the pattern of damage to the acetabular cartilage: femoroacetabular impingement as a cause of early osteoarthritis of the hip. J Bone Joint Surg [Br] 2005;87-B:1012-18.
55. Felson DT, Goggins J, Niu J, Zhang Y, Hunter DJ. The effect of body weight on progression of knee osteoarthritis is dependent on alignment. Arthritis Rheum 2004;50:3904-9.
56. Zalichman L, Zhang Y, Niu L, et al. The association between patellar alignment and patellofemoral joint osteoarthritis features: an MRI study. Rheumatology (Oxford) 2007;46:1303-8.
57. Lohmander LS, Eyre DR. From biomarker to surrogate outcome to osteoarthritis: what are the challenges? J Rheumatol 2005;32:1142-3.
58. Lohmander LS, Poole AR. Defining and validating the clinical role of molecular markers in osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. Second ed. Oxford: Oxford University Press, 2003:468-77.
59. Bauer DC, Hunter DJ, Abramson SB, et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 2006;14:723-7.
60. Kraus VB. Do biochemical markers have a role in osteoarthritis diagnosis and treatment? Best Pract Res Clin Rheumatol 2006;20:69-80.
61. Garnero P, Sornay-Rendu E, Arlot M, Christiansen C, Delmas PD. Association between spine disc degeneration and type I collagen degradation in postmenopausal women: the OFELY study. Arthritis Rheum 2004;50:3137-44.
62. Garnero P. Biochemical markers in osteoarthritis: will they measure up? Nat Clin Pract Rheumatol 2006;2:116-17.
63. Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S. Suggestion of nonliner or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum 2004;50:2479-88.
64. Dragomir AD, Kraus VB, Renner JB, et al. Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology. Osteoarthritis Cartilage 2002;10:687-91.
65. Garnero P, Delmas PD. Biomarkers in osteoarthritis. Curr Opin Rheumatol 2003;15:641-6.
66. Garnero P, Rousseau JC, Delmas PD. Molecular basis and clinical use of biochemical markers of bone cartilage, and synovium in joint diseases. Arthritis Rheum 2000;43:953-68.
67. Charni-Ben Tabassi N, Garnero P. Monitoring cartilage turnover. Curr Rheumatol Rep 2007;9:16-24.
68. Rousseau JC, Zhu Y, Miossec P, et al. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 2004;12:440-7.
69. Garnero P, Ayral X, Rousseau JC, et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 2002;46:2613-24.
70. Reijman M, Hazes JM, Bierma-Zeinstr SM, et al. A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum 2004;50:2471-8.
71. Charni N, Juillet F, Garnero P. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 2005;62:1081-90.
72. Garnero P, Charni N, Juillet F, Conrozier T, Vignon E. Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. Ann Rheum Dis 2006;65:1639-44.
73. Jung M, Christgau S, Lukoschek M, Henriksen D, Richter W. Increased urinary concentratuion of collagen type II C-telopeptide fragments in patients with osteoarthritis. Pathobiology 2004;71:70-6.
74. Garnero P, Mazières B, Guéguen A, et al. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol 2005;32:697-703.
75. Garnero P, Piperno M, Gineyts E, et al. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001;60:619-26.
76. Bruyere O, Collette J, Kothari M, et al. Osteoarthritis, magnetic resonance imaging, and biochemical markers: one year prospective study. Ann Rheum Dis 2006;65:1050-4.
77. Mazières B, Garnero P, Gruéguen A, et al. Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis: the ECHODIAH cohort. Ann Rheum Dis 2006;65:354-9.
78. Ding C, Garnero P, Cicuttini F, et al. Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown. Osteoarthritis Cartilage 2005;13:198-205.
79. Cibere J, Zhang H, Thorne A, et al. Urine CTX-II and Urine C2C are differentially associated with radiographic and pre-radiographic knee osteoarthritis (OA): results of a population based study using MRI. Arthritis Rheum 2006;54(Suppl):160.
80. Landewé R, Geusens P, Boers M, et al. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis Rheum 2004;50:1390-9.
81. Spector TD, Conaghan PG, Buckand-Wright JC, et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther 2005;7:625-33.
82. Bingham CO 3rd, Buckland-Wright JC, Garnero P, et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006;54:3494-507.
83. Sumer EU, Sondergaard BC, Rousseau JC, et al. MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays. Osteoarthritis Cartilage 2007;15:212-21.
84. Pratta MA, Su JL, Leesnitzer MA, et al. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments. Osteoarthritis Cartilage 2006;14:702-13.
85. King KB, Lindsey CT, Dunn TC, et al. A study of the relationship between molecular biomarkers of joint degeneration and the magnetic resonance-measured characteristics of cartilage in 16 symptomatic knees. Magn Reson Imaging 2004;22:1117-23.
86. Vilím V, Vytásek R, Olejárová M, et al. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis. Osteoarthritis Cartilage 2001;9:612-18.
87. Elliott AL, Kraus VB, Luta G, et al. Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 2005;52:105-11.
88. Goldberg RL, Huff JP, Lenz ME, et al. Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991;34:799-807.
89. Belo JN, Berger MY, Reijman M, Koes BW, Bierma-Zeinstra SM. Prognostic factors of progression of osteoarthritis of the knee: a systematic review of observational studies. Arthritis Rheum 2007;57:13-26.
90. Wolfe F. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol 1997;24:1486-8.
91. Conrozier T, Carlier MC, Mathieu P, et al. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis 2000;59:828-31.
92. Sowers M, Jannausch M, Stein E, et al. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage 2002;10:595-601.
93. Sharif M, Shepstone L, Elson CJ, Dieppe PA, Kirwan JR. Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis 2000;59:71-4.
94. Matyas JR, Atley L, Ionescu M, Eyre DR, Poole AR. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum 2004;50:543-52.
95. Ralston SH. New developments in the search for genetic determinants of osteoarthritis. Osteoarthritis Cartilage 2007;15:117-19.
96. Valdes AM, Loughlin J, Oene MV, et al. Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee. Arthritis Rheum 2007;56:137-46.
97. Chitnavis J, Sinsheimer J, Clipsham K, et al. Genetic influences in end-stage osteoarthritis: sibling risks of hip and knee replacement for idiopathic osteoarthritis. J Bone Joint Surg [Br] 1997;79-B:660-4.
98. McDonnell SM, Sinsheimer J, Price AJ, Carr AJ. Genetic influences in the aetiology of anteromedial osteoarthritis of the knee. J Bone Joint Surg [Br] 2007;89-B:901-3.
99. Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D. Genetic influences on osteoarthritis in women: a twin study. BMJ 1996;312:940-3.
100. Spencer JM, Loughlin J, Clipsham K, Carr AJ. Genetic background increases the risk of hip osteoarthritis. Clin Orthop 2005;431:134-7.
101. Botha-Scheepers SA, Watt I, Slagboom E, et al. Influence of familial factors on radiologic disease progression over two years in siblings with osteoarthritis at multiple sites: a prospective longitudinal cohort study. Arthritis Rheum 2007;57:626-32.
102. Zhai G, Hart DJ, Kato BS, MacGregor A, Spector TD. Genetic influence on the progression of radiographic knee osteoarthritis: a longitudinal twin study. Osteoarthritis Cartilage 2007;15:222-5.
103. Valdes AM, Hart DJ, Jones KA, et al. Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Arthritis Rheum 2004;50:2497-507.
104. Aigner T, Bartnik E, Sohler F, Zimmer R. Functional genomics of osteoarthritis: on the way to evaluate disease hypotheses. Clin Orthop 2004;427(Suppl):138-43.
105. Goronzy JJ, Matteson EL, Fulbright JW, et al. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum 2004;50:43-54.